Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medicure Inc V.MPH

Alternate Symbol(s):  MCUJF

Medicure Inc. is a pharmaceutical company. It is focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market. The focus of it is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company... see more

TSXV:MPH - Post Discussion

Medicure Inc > New Article
View:
Post by prophetoffactz on Sep 27, 2022 4:51pm

New Article

As the CEO continues to buy shares here's a new article suggesting why. Some of the top clinicians in the world are involved with a study about to commence in Q4. Approval could be a game-changer. MPH has already received a Priority Review Voucher that could be worth US$100-US$200 million.

Pg. 20:
Insights Magazine - BIOTECanada (biotech.ca)
Comment by Winnipeg40 on Oct 15, 2022 12:42pm
They do NOT have a priorty review voucher.  They may be eligible to receive one however.  My prediction is that before the trial is completed, MPH will be out of money, the drugstore purchase is a disaster and Zypitimag sales are not increasing in line with what they paid (at least supposed to have paid as I have not seen any payments through the cash flow statement lately)  and ...more  
Comment by prophetoffactz on Oct 16, 2022 2:12pm
The CEO has purchased >$60,000 worth of stock in the last five months. He's comfortable with MPH's direction. There has been no insider selling. AGGRASTAT's price has already been crushed by other drugs on the market that went off patent so there may not be much price erosion left for an off-patent version. It's only a $12 million market so most companies won't care and MPH ...more  
Comment by Winnipeg40 on Oct 17, 2022 4:56pm
Aggrastat's net realized price to MPH will likely decrease over the next 12-24 months by 50%-75%.  Contracts with US hospitals are typically for one year and that is for pricing. If an alternative is offered, they can just stop buying. There are no volume guarantees..period Zypitimag was purchased for several million dollars although looking a their last few cash flow statements it does ...more  
Comment by prophetoffactz on Oct 18, 2022 9:37pm
"Aggrastat's net realized price to MPH will likely decrease over the next 12-24 months by 50%-75%." Given MPH's gross margin last quarter was only 58.6% there is no chance of that. The drug business isn't a charity. The price of AGGRASTAT has already been hit by generic competition. MPH is a long and trusted supplier of the product and has been contracting with patent ...more  
Comment by prophetoffactz on Oct 21, 2022 10:47pm
The CEO has now bought >$71,000 worth of shares in recent months having added another $11,000 last Friday.
Comment by Winnipeg40 on Oct 27, 2022 11:22pm
That would be about 1/2 the related party fees he takes in LOL  Not to mention a 300K salary for someone who made an investment a few years ago with MPH's money of 10 Million and was written down within a year to ZERO.....and with a 300K Salary, what is the "President" doing at 170K....that is a very expensive butt kisser yes man
Comment by prophetoffactz on Dec 01, 2022 11:26am
CEO buys another $16,720 worth of stock further adding to his recent buys. $16,720 +15,200 vol $1.10 each
Comment by prophetoffactz on Dec 08, 2022 7:29pm
CEO buys another $14,140 worth of stock as he continues to add to his holdings.
Comment by prophetoffactz on Dec 30, 2022 8:40am
CEO buys another $67,000 since last post.
Comment by Winnipeg40 on Jan 18, 2023 10:09pm
Great deal...take a bunch of cash out of the Company in related party transactions, an inflated CEO salary for working part-time and 60% of time on multiple other Companies, private and public while in Florida a good part of the year, charge rent for more office space than double what is needed and then use the funds to buy more shares.  Great gig if you have no morals
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities